TABLE I.
Characteristic | Oral (n=36), No. (%) | Oropharynx (n=36), No. (%) |
---|---|---|
Age | ||
Median | 61.6 | 59.3 |
Range | 29–89 | 38–83 |
Sex | ||
Male | 17 (47) | 30 (83) |
Female | 19 (53) | 6 (17) |
Disease presentation | ||
Recurrence | 35 (97) | 33 (92) |
Second primary | 1 (3) | 3 (8) |
Prior chemotherapy | ||
Yes | 12 (33) | 17 (47) |
No | 24 (67) | 21 (53) |
Prior surgery | ||
Yes | 24 (67) | 14 (39) |
No | 12 (33) | 22 (61) |
Recurrent T staging | ||
1 | 3 (8) | 2 (6) |
2 | 4 (11) | 9 (25) |
3 | 4 (11) | 13 (36) |
4 | 23 (64) | 12 (33) |
Unknown | 2 (6) | 0 (0) |
Recurrent N staging | ||
0 | 27 (75) | 25 (69) |
1 | 1 (3) | 1 (3) |
2 | 6 (17) | 9 (25) |
3 | 0 (0) | 1 (3) |
Unknown | 2 (6) | 0 (0) |
Year from prior radiotherapy | ||
<0.5 | 7 (19) | 9 (25) |
0.5–2 | 16 (44) | 16 (44) |
>2 | 13 (36) | 11 (31) |